Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : AMYT save search
Poolbeg Pharma PLC Announces Director/PDMR Shareholding
Published: 2024-02-22 (Crawled : 10:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma
Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP
Published: 2024-02-15 (Crawled : 09:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma change
Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
Published: 2024-02-12 (Crawled : 10:00) - biospace.com/
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma market
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
Published: 2024-01-17 (Crawled : 11:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
polb001 pharma cancer potential
Poolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis Update
Published: 2023-12-20 (Crawled : 09:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma drug candidate update rsv
Poolbeg Pharma PLC Announces POLB 001 Data Presented at ASH
Published: 2023-12-11 (Crawled : 09:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma
Poolbeg Pharma PLC Announces Directorate Change
Published: 2023-11-30 (Crawled : 09:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma change
Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan
Published: 2023-11-21 (Crawled : 09:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma patent japan granted
Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS
Published: 2023-11-16 (Crawled : 12:30) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma trial
Former Amryt Pharma Leadership Team join Poolbeg
Published: 2023-11-09 (Crawled : 10:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma
Global Oral Proteins and Peptides Market Valued at $1.57 Billion in 2022, Driven by Rising Demand for Oral Treatments
Published: 2023-09-12 (Crawled : 00:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.89%
H: 0.37%
C: -2.49%
NVO | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -2.21%
H: 1.23%
C: 0.11%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.22%
H: 0.33%
C: -1.1%
global market
Alessandro Chiesi appointed Chair of the Chiesi Group Maria Paola Chiesi becomes the Vice Chair
Published: 2023-07-07 (Crawled : 09:00) - prnewswire.com
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
group
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
Published: 2023-04-12 (Crawled : 12:00) - prnewswire.com
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma acquisition
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
Published: 2023-03-22 (Crawled : 18:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
pharma acquisition
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Published: 2023-01-08 (Crawled : 20:20) - globenewswire.com
MC | $50.97 -0.57% 0.0% 370K
|
Finance
|
| O: 0.09%
H: 2.68%
C: 0.85%
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: 106.53%
H: 0.0%
C: 0.0%
pharma acquire
COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
Published: 2022-12-19 (Crawled : 15:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -1.08%
H: 2.9%
C: 1.59%
mycapssa treatment designation tumors positive
European Commission approves Mycapssa® for the treatment of Acromegaly
Published: 2022-12-05 (Crawled : 19:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
mycapssa treatment
Amryt Announces New Patent for Mycapssa® - November 30, 2022
Published: 2022-11-30 (Crawled : 13:20) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -0.71%
H: 4.02%
C: 2.15%
mycapssa patent
Amryt Announces New Patent for Mycapssa®
Published: 2022-11-30 (Crawled : 12:20) - globenewswire.com
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -0.71%
H: 4.02%
C: 2.15%
mycapssa patent
The British Journal of Dermatology Publishes Results from Amryt’s EASE Phase 3 Trial in Epidermolysis Bullosa
Published: 2022-10-25 (Crawled : 11:00) - globenewswire.com
AMYT | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -2.71%
H: 2.06%
C: 2.06%
trial results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.